Reynders Mc Veigh Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Reynders Mc Veigh Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $178,857 - $253,477	-700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $17,569 - $22,434	-50 Reduced 6.67%	700 $264,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $46,580 - $57,287	-125 Reduced 14.29%	750 $310,000
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $22,062 - $27,873	-75 Reduced 7.89%	875 $324,000
Q1 2021 May 07, 2021	SELL	$249.67 - $299.48 $37,450 - $44,922	-150 Reduced 13.64%	950 $275,000
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $244,200 - $277,882	1,100 New	1,100 $275,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.